Thornburg Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$599K	Sell	10,608 -80,122	-88%	-$4.67M	0.01%	151
2025 Q4	$5.39M	Buy	90,730 +17,585	+24%	+$957K	0.07%	119
2025 Q3	$3.96M	Sell	73,145 -4,865	-6%	-$278K	0.05%	137
2025 Q2	$4.29M	Sell	78,010 -7,417	-9%	-$437K	0.06%	135
2025 Q1	$60.4M	Sell	85,427 -11,454	-12%	-$771K	0.08%	118
2024 Q4	$6.37M	Sell	96,881 -26	-0%	-$1.74K	0.08%	128
2024 Q3	$6.81M	Sell	96,907 -64,539	-40%	-$5.39M	0.09%	133
2024 Q2	$13.3M	Sell	161,446 -3,546	-2%	-$295K	0.19%	81
2024 Q1	$14.4M	Sell	164,992 -5,810	-3%	-$520K	0.2%	83
2023 Q4	$16.5M	Sell	170,802 -105,276	-38%	-$9.31M	0.24%	69
2023 Q3	$24.4M	Buy	276,078 +18,775	+7%	+$1.67M	0.4%	53
2023 Q2	$22.3M	Buy	257,303 +105,528	+70%	+$9.93M	0.36%	56
2023 Q1	$14.8M	Buy	+151,775	New	+$15.7M	0.24%	75